Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maruyama, K.
Right arrow Articles by Yanagisawa, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maruyama, K.
Right arrow Articles by Yanagisawa, N.

Stroke, Vol 21, 397-403, Copyright © 1990 by American Heart Association


ARTICLES

Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C

K Maruyama, S Ikeda, T Ishihara, D Allsop and N Yanagisawa
Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

Using immunohistochemical staining methods with antibodies to amyloid beta protein and human cystatin C, we examined cerebrovascular amyloid protein in the brains from 46 cases with cerebral amyloid angiopathy (seven with Alzheimer's disease, one with Down's syndrome, 18 with intracranial hemorrhage, 10 with cerebral infarction, and 10 elderly patients without any neurologic disorder). All cerebrovascular amyloid deposits in these 46 cases were consistently immunoreactive to anti- beta protein antibody. However, in nine cases some vascular walls with strong beta protein immunoreactivity also reacted less intensely with the anti-cystatin C antiserum. Of these nine cases, seven showed relatively heavy cerebrovascular amyloid deposition, and all seven had suffered a fatal subcortical hemorrhage presumably caused by cerebral amyloid angiopathy. Previous limited studies have suggested that the amyloid protein seen in elderly individuals with cerebral amyloid angiopathy is composed of beta protein. However, subcortical hemorrhage rarely occurs in such individuals. Our study shows that aged patients with different brain disorders commonly suffer from beta protein-type cerebral amyloid angiopathy, and we also suggest that the severity of beta protein-type cerebrovascular amyloid deposition is a fundamental factor in cerebral amyloid angiopathy-induced brain hemorrhage in the elderly. The nature of the cystatin C-immunoreactive substance in some of these vascular lesions is uncertain, but it might conceivably play an additional important role in the pathogenesis of brain hemorrhage in these cases.


This article has been cited by other articles:


Home page
NeurologyHome page
J. Sundelof, J. Arnlov, E. Ingelsson, J. Sundstrom, S. Basu, B. Zethelius, A. Larsson, M. C. Irizarry, V. Giedraitis, E. Ronnemaa, et al.
Serum cystatin C and the risk of Alzheimer disease in elderly men
Neurology, September 30, 2008; 71(14): 1072 - 1079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Deng, M. C. Irizarry, R. M. Nitsch, J. H. Growdon, and G. W. Rebeck
Elevation of Cystatin C in Susceptible Neurons in Alzheimer's Disease
Am. J. Pathol., September 1, 2001; 159(3): 1061 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. T. Winkler, L. Bondolfi, M. C. Herzig, L. Jann, M. E. Calhoun, K.-H. Wiederhold, M. Tolnay, M. Staufenbiel, and M. Jucker
Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy
J. Neurosci., March 1, 2001; 21(5): 1619 - 1627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Melchor and W. E. Van Nostrand
Fibrillar Amyloid beta -Protein Mediates the Pathologic Accumulation of Its Secreted Precursor in Human Cerebrovascular Smooth Muscle Cells
J. Biol. Chem., March 24, 2000; 275(13): 9782 - 9791.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Wei, L. C. Walker, E. Levy, and W. I. Rosenblum
Cystatin C: Icelandic-Like Mutation in an Animal Model of Cerebrovascular ß-Amyloidosis
Stroke, November 1, 1996; 27(11): 2080 - 2085.
[Abstract] [Full Text]


Home page
StrokeHome page
C. Graffagnino, M. H. Herbstreith, D. E. Schmechel, E. Levy, A. D. Roses, and M. J. Alberts
Cystatin C Mutation in an Elderly Man With Sporadic Amyloid Angiopathy and Intracerebral Hemorrhage
Stroke, November 1, 1995; 26(11): 2190 - 2193.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. E. Van Nostrand, J. P. Melchor, H. S. Cho, S. M. Greenberg, and G. W. Rebeck
Pathogenic Effects of D23N Iowa Mutant Amyloid beta -Protein
J. Biol. Chem., August 24, 2001; 276(35): 32860 - 32866.
[Abstract] [Full Text] [PDF]